Patents by Inventor Hua-Yu Leo Wang

Hua-Yu Leo Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20230271926
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: May 10, 2023
    Publication date: August 31, 2023
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. McHARDY, Francisco Xavier RUIZ, Ambrosio LOPEZ, Bismarck CAMPOS, Hua-Yu Leo WANG
  • Inhibition of Olig2 activity
    Patent number: 11691951
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: July 4, 2023
    Assignee: CURTANA PHARMACEUTICALS, INC.
    Inventors: Graham Beaton, Fabio C. Tucci, Satheesh B. Ravula, Stanton F. McHardy, Francisco Xavier Ruiz, Ambrosio Lopez, Bismarck Campos, Hua-Yu Leo Wang
  • Inhibition of Olig2 activity
    Patent number: 11685722
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: June 27, 2023
    Assignee: CURTANA PHARMACEUTICALS, INC.
    Inventors: Graham Beaton, Stanton F. McHardy, Ambrosio Lopez, Jr., Bismarck Campos, Hua-Yu Leo Wang
  • Inhibition of OLIG2 activity
    Patent number: 11242323
    Abstract: Described herein are urea compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: February 8, 2022
    Assignee: CURTANA PHARMACEUTICALS, INC.
    Inventors: Graham Beaton, Stanton F. McHardy, Ambrosio Lopez, Jr., Bismarck Campos, Hua-Yu Leo Wang
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20210347739
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: July 2, 2021
    Publication date: November 11, 2021
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. McHARDY, Francisco Xavier RUIZ, Ambrosio LOPEZ, Bismarck CAMPOS, Hua-Yu Leo WANG
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20210253535
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: April 19, 2021
    Publication date: August 19, 2021
    Inventors: Graham BEATON, Stanton F. McHARDY, Ambrosio LOPEZ, Jr., Bismarck CAMPOS, Hua-Yu Leo WANG
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20210114991
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: November 20, 2020
    Publication date: April 22, 2021
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. McHARDY, Francisco Xavier RUIZ, Ambrosio LOPEZ, Bismarck CAMPOS, Hua-Yu Leo WANG
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20200407329
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: February 28, 2019
    Publication date: December 31, 2020
    Inventors: Graham BEATON, Stanton F. McHARDY, Ambrosio LOPEZ, Jr., Bismarck CAMPOS, Hua-Yu Leo WANG
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20190389812
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: August 25, 2017
    Publication date: December 26, 2019
    Inventors: Graham BEATON, Stanton F. McHARDY, Ambrosio LOPEZ, JR., Bismarck CAMPOS, Hua-Yu Leo WANG
  • INHIBITION OF OLIG2 ACTIVITY
    Publication number: 20180244631
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
    Type: Application
    Filed: February 26, 2016
    Publication date: August 30, 2018
    Inventors: Graham BEATON, Fabio C. TUCCI, Satheesh B. RAVULA, Stanton F. MCHARDY, Francisco Xavier RUIZ, III, Ambrosio LOPEZ, Jr., Bismarck CAMPOS, Hua-Yu Leo WANG
  • GLYCOSYLATED CARDIOTONIC STEROIDS
    Publication number: 20160176914
    Abstract: Compounds which are glycosylates of an A-ring of a cardiotonic steroid, wherein the steroid is attached to the anomeric position of (a) a monosaccharide comprising a C-4 amino group, or (b) an oligosaccharide are provided.
    Type: Application
    Filed: May 29, 2014
    Publication date: June 23, 2016
    Inventors: George A. O'Doherty, Hongyan Li, Sumit O. Bajaj, Hua-Yu Leo Wang, Michael F. Cuccarese, Ravit Boger